Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.730
+0.030 (0.81%)
At close: May 12, 2025, 4:00 PM
3.826
+0.096 (2.57%)
After-hours: May 12, 2025, 6:54 PM EDT
Rezolute Employees
Rezolute had 59 employees as of June 30, 2024. The number of employees increased by 8 or 15.69% compared to the previous year.
Employees
59
Change (1Y)
8
Growth (1Y)
15.69%
Revenue / Employee
n/a
Profits / Employee
-$1,205,661
Market Cap
225.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RZLT News
- 7 days ago - Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism - GlobeNewsWire
- 11 days ago - Rezolute to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 11 days ago - Rezolute: RZ402 Could Be A Surprise Candidate In The Making - Seeking Alpha
- 17 days ago - Rezolute, Inc. Announces Closing of Underwritten Offering - GlobeNewsWire
- 19 days ago - Rezolute 'Thrilled' With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December - Benzinga
- 19 days ago - Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 19 days ago - Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism (“HI”) - GlobeNewsWire
- 6 weeks ago - Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors - GlobeNewsWire